In a recent case, the North Carolina Supreme Court tackled the complex issue of software licenses and contracts within the framework of lucrative service packages in the Value Health Solutions, Inc. v. Pharmaceutical Research Associates, Inc., 891 S.E.2d 100 (2023). At the heart of the issue, the court grappled with the question: if a company contracts to acquire software, and then licenses that software to a third party as part of a profitable service package, did it technically “sell” the software?
The case revolves around a clinical research organization (CRO), the defendant, which had entered into an approximately $491 million, multi-year contract with a client that included a license of specific software. The terms of the contract and the nature of the software license within the context of the high-value package brought forth the need for the court to assess what counts as a sale in these circumstances.
While a dollar amount and terms were agreed upon within this contract, the specific role and licensure of the software threw a curveball into the precedents of contractual agreements. The implications of this case will undoubtedly inform future discussions and considerations on software licensing, especially within the context of service contracts.
As this case unfolds, legal professionals should closely follow the developments to better understand how such large-scale software licensing agreements are being evaluated by the court, and to inform their negotiation and drafting of similar contracts in the future.